Hertford, United Kingdom · Founded 2017 · Privately Held (backing)
Operator of a vaccine antigen design company intended to accelerate vaccine development to maximize the protection against existing and future viruses. DIOSynVax is based in Hertford, United Kingdom and was founded in 2017. Its last reported valuation was $31.6 million in Dec 2025. It has raised $9.8 million.
These 7 firms already write checks for companies like DIOSynVax. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.